Fecal Microbiota Transplant Modulates Clostridium Clusters XIVa, IV, and Caudovirales Bacteriophages to Induce Remission in Ulcerative Colitis Patients
Adam Saleh
Introduction: Ulcerative Colitis (UC) is a chronic idiopathic inflammatory disorder of the colon with continuous inflammation beginning in the rectum and ascending proximally. The disease can present clinically with varying severity of diarrhea and blood in stool, urgency, and tenesmus1. The pathogenesis of UC likely has contributions from various factors including genetics, environment, and gut microbiota composition2. Microbiota alterations associated with the development of UC include enteric infections, antibiotic use, high dietary intake of total fats, PUFAs, and proteins3–5. Fecal Microbiota Transplant (FMT) is an experimental form of therapy defined by the transfer of healthy donor stool to the patient. Methods: A significant percentage of research being done to identify FMT mechanisms of action has been focused on correlations between bacterial and viral populations present in responders and non-responders. In this review, the mechanisms behind these prevalent correlations are presented to suggest a multifactorial mechanism for FMT induction of remission. Results: UC patients at baseline have been shown to have a reduced number of bacteria from Clostridium cluster IV and XIVa when compared to their healthy counterparts. Clostridium Clusters IV,XIVa also have been shown to be associated with positive response to FMT in multiple studies with mean relative abundance shifting towards donor levels after FMT therapy6. The mechanism through which Clostridium Clusters IV and XIVa affect inflammation was demonstrated in murine models where they successfully suppressed colitis through the induction of IL-10-producing regulatory T (Treg) cells in dextran sodium sulfate (DSS) mice models7–9. Additionally, the enteric virome for patients with UC shows an increased species richness defined by the number of taxa present10. There is an increase in bacteriophages with the most prominent change being in the population of Caudovirales in the intestinal microbiota10–12. These Caudovirales bacteriophages are present in increased levels in patients that do not respond to FMT. When murine models were exposed to Caudovirales bacteriophaghes, a larger proportion of cells exhibited an activated phenotype with more IFN-gamma and IL-17a producing T cells11. Conclusions: The mechanism through which FMT is capable of inducing remission likely involves multiple bacterial and viral species such as Caudovirales bacteriophages and Clostridium Clusters IV and IVa. This review suggests that there is sufficient data available to begin targeted therapy in conjunction with FMT to help improve FMT response. Additionally, prescreening should be performed on the patients and donors and evaluated for Caudovirales and Clostridum Clusters IV and IVa levels.
- Gajendran M, Loganathan P, Jimenez G, et al. A comprehensive review and update on ulcerative colitis,. Dis Mon. 2019;65(12):100851. doi:10.1016/j.disamonth.2019.02.004
- Feuerstein JD, Moss AC, Farraye FA. Ulcerative Colitis. Mayo Clin Proc. 2019;94(7):1357-1373. doi:10.1016/j.mayocp.2019.01.018
- Sekirov I, Finlay BB. The role of the intestinal microbiota in enteric infection: Intestinal microbiota and enteric infections. J Physiol. 2009;587(17):4159-4167. doi:10.1113/jphysiol.2009.172742
- Nguyen LH, Örtqvist AK, Cao Y, et al. Antibiotic use and the development of inflammatory bowel disease: a national case-control study in Sweden. Lancet Gastroenterol Hepatol. 2020;5(11):986-995. doi:10.1016/S2468-1253(20)30267-3
- Hou JK, Abraham B, El-Serag H. Dietary Intake and Risk of Developing Inflammatory Bowel Disease: A Systematic Review of the Literature. Am J Gastroenterol. 2011;106(4):563-573. doi:10.1038/ajg.2011.44
- Fuentes S, Rossen NG, van der Spek MJ, et al. Microbial shifts and signatures of long-term remission in ulcerative colitis after faecal microbiota transplantation. ISME J. 2017;11(8):1877-1889. doi:10.1038/ismej.2017.44
- Hayashi A, Sato T, Kamada N, et al. A Single Strain of Clostridium butyricum Induces Intestinal IL-10-Producing Macrophages to Suppress Acute Experimental Colitis in Mice. Cell Host Microbe. 2013;13(6):711-722. doi:10.1016/j.chom.2013.05.013
- Atarashi K, Tanoue T, Shima T, et al. Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species. Science. 2011;331(6015):337-341. doi:10.1126/science.1198469
- Atarashi K, Tanoue T, Oshima K, et al. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature. 2013;500(7461):232-236. doi:10.1038/nature12331
- Norman JM, Handley SA, Baldridge MT, et al. Disease-Specific Alterations in the Enteric Virome in Inflammatory Bowel Disease. Cell. 2015;160(3):447-460. doi:10.1016/j.cell.2015.01.002
- Gogokhia L, Buhrke K, Bell R, et al. Expansion of Bacteriophages Is Linked to Aggravated Intestinal Inflammation and Colitis. Cell Host Microbe. 2019;25(2):285-299.e8. doi:10.1016/j.chom.2019.01.008
- Wagner J, Maksimovic J, Farries G, et al. Bacteriophages in Gut Samples From Pediatric Crohn’s Disease Patients: Metagenomic Analysis Using 454 Pyrosequencing. Inflamm Bowel Dis. 2013;19(8):1598-1608. doi:10.1097/MIB.0b013e318292477c